Food makers focus on Ozempic supplements and side dishes
[ad_1]
Major food manufacturers have already acknowledged that the sudden and extreme popularity of a new generation of weight loss drugs could potentially threaten profits if they don't adapt. Semaglutides like Ozempic and Wegovy, prescribed to treat Type 2 diabetes, are also now being used for weight loss given that they suppress the appetite. Food makers are keeping a close eye on how they might change Americans' consumption patterns on a large scale. "Food companies are really in the early stages of trying to assess what the impact is going to be," Jesse Newman, food and agriculture reporter for the Wall Street Journal, told CBS News. Investors in major food brands are also "concerned that this could threaten sales down the road," she added. But in addition to threatening a potential reduction in demand from suppressed consumption, the drugs could also present new opportunities for food makers. It